Regulatory round-up: Novartis, Sanofi and Arrowhead secure CHMP blessings
The European drug market could soon be poised to receive three new entries, as the European Committee for…
Recursion Pharmaceuticals Details AI-Driven Drug Pipeline, Sanofi/Roche Milestones, Runway to 2028
Recursion Pharmaceuticals logo Recursion has merged Exscientia’s AI-driven chemistry with its own phenomics and a new ClinTech real-world-data…
FDA pushes back decision on Sanofi’s BTK inhibitor; Roche makes a deal with Starpharma
Plus, news about Sciwind Biosciences, Ipsen, Genfit, Ascletis, AusperBio, Ensoma, Jasper Therapeutics, Verrica, Incyte and Johnson & Johnson:…
Roche pill succeeds in another MS study, but approval questions linger
This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free…
Data builds on Roche’s dominance in primary progressive MS
Roche has revealed the data behind a positive phase 3 trial for its oral BTK inhibitor fenebrutinib in…